Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TACE(Transcatheter Arterial Chemoembolization)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03636620
What this trial is testing

TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial

Who this might be right for
Hepatocellular Carcinoma
Fudan University 110
Testing effectiveness (Phase 2)Study completedNCT04599790
What this trial is testing

TACE Combined With Lenvatinib and Sintilimab for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 30
Post-approval studies (Phase 4)Study completedNCT06041425
What this trial is testing

The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial ChemoembolizationPain+1 more
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT07398664
What this trial is testing

H101 Plus TACE for r/m HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaOncolytic VirusTACE
West China Hospital 20
Not applicableActive Not RecruitingNCT07065786
What this trial is testing

A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy

Who this might be right for
Transcatheter Arterial ChemoembolizationUnresectable Hepatocellular Carcinoma
Zhongda Hospital 550
Not applicableLooking for participantsNCT06898398
What this trial is testing

TACE Combined Surgery for the Resectable Huge HCC

Who this might be right for
Hepatocellular CarcinomaHepatic ChemotherapyLiver Cancer+1 more
Sun Yat-sen University 326
Not applicableLooking for participantsNCT06602011
What this trial is testing

Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)

Who this might be right for
Hepatocellular Carcinoma
Fujian Provincial Hospital 20
Post-approval studies (Phase 4)UnknownNCT02253511
What this trial is testing

A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zheng Donghai 400
Not applicableUnknownNCT03285867
What this trial is testing

Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Failure
Nanfang Hospital, Southern Medical University 200
Large-scale testing (Phase 3)UnknownNCT02971345
What this trial is testing

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Shanghai Zhongshan Hospital 253
Large-scale testing (Phase 3)Study completedNCT01833299
What this trial is testing

Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaFace Cancer
Sun Yat-sen University 120
Post-approval studies (Phase 4)UnknownNCT01415063
What this trial is testing

Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaRFATACE
Sun Yat-sen University 120
Testing effectiveness (Phase 2)UnknownNCT02862613
What this trial is testing

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Who this might be right for
Precision CellsTranscatheter Arterial ChemoembolizationAdvanced Liver Cancer
Shanghai International Medical Center 40
Not applicableStudy completedNCT07277192
What this trial is testing

HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival

Who this might be right for
Hepatecellular CarcinomaLiver InjuryHAIC(Hepatic Artery Infusion Chemotherapy)+1 more
Nanfang Hospital, Southern Medical University 562
Not applicableWithdrawnNCT00746655
What this trial is testing

SBRT + TACE for Primary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Pittsburgh
Testing effectiveness (Phase 2)Ended earlyNCT01379521
What this trial is testing

Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 65
Not applicableLooking for participantsNCT06740370
What this trial is testing

TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial ChemoembolizationAnti-PD1 Antibody+1 more
Sun Yat-sen University 32
Testing effectiveness (Phase 2)UnknownNCT00990860
What this trial is testing

Study in Asia of the Combination of TACE With Sorafenib in HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan 36
Not applicableUnknownNCT02537158
What this trial is testing

Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection

Who this might be right for
Hepatocellular Carcinoma
Chinese Academy of Medical Sciences 90
Testing effectiveness (Phase 2)UnknownNCT05135364
What this trial is testing

HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure

Who this might be right for
Unresectable Hepatocellular Carcinoma
Yue Han 48
Next Page